Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study.

Autor:	Sharma P; Mayo Clinic Health System, 1221 Whipple St., Eau Claire, WI 54703, USA., Holland A; Mayo Clinic Health System, 1221 Whipple St., Eau Claire, WI 54703, USA., Sheikh T; Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA., Novy B; Mayo Clinic, 200 First St. SW Rochester, MN 55905, USA., Oesterle T; Mayo Clinic, 200 First St. SW Rochester, MN 55905, USA., Platt R; Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA., Hammond CJ; Johns Hopkins School of Medicine, 733 N Broadway, Baltimore, MD 21205, USA.
Jazyk:	angličtina
Zdroj:	PEC innovation [PEC Innov] 2022 Apr 28; Vol. 1, pp. 100044. Date of Electronic Publication: 2022 Apr 28 (Print Publication: 2022).
DOI:	10.1016/j.pecinn.2022.100044
Abstrakt:	Objectives: Federal hemp legalization and ongoing shifts in US marijuana laws have led to increased population-wide use of cannabidiol (CBD) supplements, often without the knowledge of primary healthcare providers (PCPs). Given the potential risks related to CBD use, especially in vulnerable subgroups, improved communication is warranted. This study aimed to examine PCP attitudes, experiences, and practice behaviors related to CBD and provider-reported barriers to communication with patients about CBD use. Methods: Fourteen PCPs were recruited and participated in semi-structured interviews. Transcripts were digitally analyzed using inductive thematic analysis. Results: Analyses identified that most PCPs had neutral views about CBD use by their patients. The study found that discussions about CBD use were initiated by patients. Most PCPs cited lack of time, discomfort, low-quality evidence, and low prioritization as reasons for not discussing CBD with patients. Conclusion: PCPs rarely screen for or discuss CBD use with their patients and most of them had neutral views about CBD use by their patients. A number of barriers exist to open dialogue about CBD. Innovation: Our study is the first in-depth report on PCP attitudes, experiences, and practice behaviors related to CBD. The findings of our study have the potential to significantly impact future PCP practice behaviors. These results can inform healthcare system policies around screening for CBD use and PCP communication training. In doing so, these efforts may mitigate risk and optimize benefits related to the expanding CBD market. Competing Interests: Authors have no competing interests. Mayo Clinic Health System, Office of Research provided funding support for this study. (© 2022 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu